3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
2
Skin Neoplasms
1
Sarcoma
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Autoimmune Diseases
1
Interventions
pembrolizumab
8
avelumab
6
fludarabine
3
Radiotherapy
3
Radiation
3
Cyclophosphamide
3
cemiplimab
2
atezolizumab
2
aldesleukin
2
Interleukin-2
2
Interferon-beta
2
ALT-803
2
talimogene laherparepvec
1
poly ICLC
1
pentetreotide
1
interferon gamma-1b
1
epacadostat
1
efineptakin alfa
1
durvalumab
1
cabozantinib
1
bempegaldesleukin
1
TTI-621
1
Paclitaxel
1
Nivolumab
1
Interferon-gamma
1
Influenza Vaccines
1
Immunotherapy
1
High-Intensity Focused Ultrasound Ablation
1
Carboxylesterase
1
B7-H1 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Carcinoma, Merkel Cell
×
Immunotherapy
×
Clear all
NCT03370861
2024-09-05
MINING
Washington University School of Medicine
Terminated
54 enrolled